New River names John Thottathil chief scientific officer

By Lisa Kerner

Erie, Pa., April 11 - New River Pharmaceuticals Inc. said John Thottathil, Ph.D., has joined the company as chief scientific officer and will lead the company's research and discovery programs from its laboratories at the Virginia Tech Corporate Research Center in Blacksburg, Va.

"Dr. Thottathil brings to New River the skills and experience to manage complex projects and to lead cross-functional teams that deliver consistent results on schedule, on budget, and at the highest levels of quality," chief executive officer R. J. Kirk said in a news release.

"Our team looks forward to working with him to bolster our pipeline and to advance new compounds toward regulatory approval."

Prior to joining New River, Thottathil was the director of core research and development chemistry, diagnostic division, at Abbott Laboratories. He has also held various positions in a 19-year career at Bristol-Myers Squibb.

Thottathil is credited with several projects that resulted in product launches and contributions to 60 patents and 40 peer-reviewed publications, the release said.

New River is a specialty pharmaceutical company based in Radford, Va.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.